Benziodarone

CHEMBL232201 Phase 4 Approved Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

518.1 g/mol

LogP

5.6

Phase

4

A benzofuranyl iodine derivative with vasodilatory and uricosuric properties that was studied for angina and gout, though it is not widely used today.

Molecular Weight

518.0800 g/mol

LogP

5.60

TPSA

50.40 Å²

Lipinski RO5

Fail

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure

Embed this structure

SMILES

CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1

InChI

InChI=1S/C17H12I2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3

Molecular Formula

C17H12I2O3

HBD / HBA

1 / 3

Rotatable Bonds

3

Heavy Atoms

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

A benzofuranyl iodine derivative with vasodilatory and uricosuric properties that was studied for angina and gout, though it is not widely used today.

Yes, Benziodarone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL232201. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 6237. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Looking for patient-friendly information?

Benziodarone on PillFYI

Structure

Quick Data

Formula: C17H12I2O3

External Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.